chr8-127415880-T-C

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001159542.3(POU5F1B):​c.14T>C​(p.Leu5Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000784 in 1,530,594 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000053 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000029 ( 0 hom. )

Consequence

POU5F1B
NM_001159542.3 missense

Scores

5
14

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: -2.50

Publications

0 publications found
Variant links:
Genes affected
POU5F1B (HGNC:9223): (POU class 5 homeobox 1B) This intronless gene was thought to be a transcribed pseudogene of POU class 5 homeobox 1, however, it has been reported that this gene can encode a functional protein. The encoded protein is nearly the same length as and highly similar to the POU class 5 homeobox 1 transcription factor, has been shown to be a weak transcriptional activator and may play a role in carcinogenesis and eye development. [provided by RefSeq, Apr 2009]
CASC8 (HGNC:45129): (cancer susceptibility 8)
PCAT1 (HGNC:43022): (prostate cancer associated transcript 1) This gene produces a long non-coding RNA that promotes cell proliferation and is upregulated in prostate, colorectal, and other cancers. This RNA negatively regulates the BRCA2 tumor suppressor protein and positively regulates Myc oncoprotein. It contains binding sites for microRNAs, and may act as a sponge for microRNAs that regulate cell growth pathways. [provided by RefSeq, Dec 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.1712296).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
POU5F1BNM_001159542.3 linkc.14T>C p.Leu5Pro missense_variant Exon 1 of 1 ENST00000696633.1 NP_001153014.1 Q06416
POU5F1BNM_001395745.1 linkc.14T>C p.Leu5Pro missense_variant Exon 2 of 2 NP_001382674.1
CASC8NR_117100.1 linkn.1176+4949A>G intron_variant Intron 5 of 5

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POU5F1BENST00000696633.1 linkc.14T>C p.Leu5Pro missense_variant Exon 1 of 1 NM_001159542.3 ENSP00000512769.1 Q06416

Frequencies

GnomAD3 genomes
AF:
0.0000394
AC:
6
AN:
152186
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.00000699
AC:
1
AN:
143080
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.000124
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000290
AC:
4
AN:
1378290
Hom.:
0
Cov.:
113
AF XY:
0.00
AC XY:
0
AN XY:
677818
show subpopulations
African (AFR)
AF:
0.000128
AC:
4
AN:
31138
American (AMR)
AF:
0.00
AC:
0
AN:
31034
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
23442
East Asian (EAS)
AF:
0.00
AC:
0
AN:
36858
South Asian (SAS)
AF:
0.00
AC:
0
AN:
75730
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
48128
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4990
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1070178
Other (OTH)
AF:
0.00
AC:
0
AN:
56792
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.488
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000525
AC:
8
AN:
152304
Hom.:
0
Cov.:
33
AF XY:
0.0000671
AC XY:
5
AN XY:
74478
show subpopulations
African (AFR)
AF:
0.000192
AC:
8
AN:
41582
American (AMR)
AF:
0.00
AC:
0
AN:
15312
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5174
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4824
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
68010
Other (OTH)
AF:
0.00
AC:
0
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.533
Heterozygous variant carriers
0
1
2
3
4
5
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000831
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Feb 19, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.14T>C (p.L5P) alteration is located in exon 1 (coding exon 1) of the POU5F1B gene. This alteration results from a T to C substitution at nucleotide position 14, causing the leucine (L) at amino acid position 5 to be replaced by a proline (P). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.027
T
BayesDel_noAF
Benign
-0.28
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.0049
T;T
Eigen
Benign
-0.29
Eigen_PC
Benign
-0.55
FATHMM_MKL
Benign
0.0030
N
LIST_S2
Benign
0.83
.;T
M_CAP
Benign
0.020
T
MetaRNN
Benign
0.17
T;T
MetaSVM
Benign
-0.42
T
MutationAssessor
Uncertain
2.0
M;M
PhyloP100
-2.5
PrimateAI
Uncertain
0.54
T
PROVEAN
Benign
0.33
.;N
REVEL
Uncertain
0.34
Sift
Uncertain
0.022
.;D
Sift4G
Benign
0.13
.;T
Polyphen
1.0
D;D
Vest4
0.30
MutPred
0.14
Gain of glycosylation at S7 (P = 0.0693);Gain of glycosylation at S7 (P = 0.0693);
MVP
0.49
MPC
0.34
ClinPred
0.26
T
GERP RS
1.4
Varity_R
0.10
gMVP
0.38
Mutation Taster
=91/9
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1012378262; hg19: chr8-128428125; API